European Health Catapult

Application Deadline


European Health Catapult is a training and competition programme that boosts the development of top-notch European health start-ups. The programme exposes BioTech, MedTech and Digital Health start-ups to high-quality experts and international investors through intensive and multi-channel involvement of the whole EIT Health community.




Basic Info

Who can apply:  The European Health Catapult is open for micro and small enterprises (< 50 employees), spin-offs and start-ups (already incorporated, looking for seed or series A funding, miniumum 500k €) from all over the EIT Health community that

  • Are active in the fields of Medtech, Biotech and Digital Health
  • Are operating in an EU Country
  • Have innovative business concepts

Detailed description: Entering the European Health Catapult gives participants the opportunity to join a unique forum for innovators with an intensive two-step selection and 360° preparation. This involves dedicated training and selection days that allow participants to optimise their business plan and strengthen their ability to pitch in front of top-level investors and industry stakeholders.
Participants gain real-world entrepreneurial experience and potential access to an international network of world-leading MedTech, BioTech, pharma and IT companies that are partners of EIT Health and Health Axis Europe. These include, but are not limited to:

● Siemens Healthineers
● Philipps
● GE Healthcare
● Medtronic
● Abbott
● AbbVie
● Roche
● Sanofi
● ThermoFischer Scientific
● Astra Zeneca
● Bayer Pharma
● Merck
● Air Liquide – as well as world-class research organisations in healthcare.

Participants will also have early access to an international network of investors (VCs, corporate VCs, business angels, crowd investors) to boost their business ideas, as well as guidance to access unique services offered by EIT Health networks in crucial areas such as clinical validation (living labs and test beds) and the mentor and expert platform.
Prize money and cost coverage:

Stage 1:
In total, 42 teams (14 per category) will be nominated from seven CLCs. These nominees will be invited to a compact training programme designed to prepare the teams and a selection day with a competition in each category. Benefits include reviewing of their business plan, pitch training, and exposure to experts and investors.

Stage 2:
Half of these semi-finalists – a total of 21 teams (seven per category) – will be chosen at the training and selection days, and will be invited to pitch at the finals during the EIT Health Summit. Travel costs will be covered.

Stage 3:
At the EIT Health Summit, the ‘best of the best’ business plans in MedTech, BioTech and Digital Health will be selected by a panel of experts. The top three finalists in these categories will receive an award based on their placing. The maximum amount of all prizes awarded will be €135,000.

Contact Details: Ines Matias (; Nuno Viegas (; Tamás Békási (

Apply here:


Scale up,
Scale out
Expected Applicants
Early stage companies and SME,
< EUR 25 000
Expected Outcome
Become Investment grade,
International sales development
Competition with awards,
Engagement Level
3 to 6 months
One EU location